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Abstract 
Purpose: To investigate the anti-inflammatory effects of nobiletin on human osteoarthritic chondrocytes 
and also to explore possible related molecular events.  
Methods: Isolated human osteoarthritic chondrocytes were stimulated with IL-1β. The effect of nobiletin 
(75, 150 or 300 µg) on chondrocyte viability was assessed. Furthermore, the effect on NO production 
was determined using Griess reagent while the levels of IL-6 and PGE2 were assessed by enzyme 
linked immunosorbent assay (ELISA). The influence of nobiletin on the expression of COX-2, iNOS and 
proteins of PI3/Akt, NF-κB and MAPK cascades were also assessed.  
Results: Nobiletin (75, 150 and 300 µg) significantly (p < 0.05) improved the viability of chondrocytes, 
and remarkably reduced the levels of NO, IL-6 and PGE2. The expression levels of COX-2 and iNOS 
both at mRNA and protein levels were strikingly reduced by nobiletin, in a dose-dependent way. In 
addition, nobiletin caused marked (p < 0.05) down-regulation of the NF-κB signalling pathway. IL-1β-
induced activation of PI3/Akt, and JNK, ERK and p38 MAPK cascades were significantly (p < 0.05) 
inhibited by nobiletin with 300 µg dose exhibiting maximum effects.  
Conclusion: Inflammatory cytokines are critically involved in the pathogenesis of OA. Significant 
suppression of cytokines and modulation of PI3/Akt and MAPK signalling cascades by nobiletin 
suggests its potent anti-inflammatory and anti-osteoarthritic effects.  
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Osteoarthritis (OA) is a degenerative 
musculoskeletal disease characterized by 
progressive damage and erosion of articular 
cartilage, osteophyte formation and subchondral 
bone sclerosis eventually leading to pain and 
disability [1,2]. Chondrocytes of the articular 
cartilage play critical roles in pathogenesis of OA 
by potentially expressing and as well responding 
to inflammatory cytokines [3]. These 
inflammatory cytokines perturb the homeostasis 
of metabolic processes in the joints [4]. 
  
IL-1β, a major cytokine in OA [5] induces the 
expression of matrix metalloproteinases (MMPs) 
such as collagenases (MMP-3 and -13). MMPs 
are involved in cartilage degradation that 
eventually leads to the release of matrix 
proteoglycans, a critical event in OA 
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pathogenesis [6]. IL-1β induces activation of NF-
κB and MAPK signalling pathways in 
chondrocytes thereby enhancing the expression 
and release of NO and PGE2 via up-regulation of 
cyclooxygenase-2 (COX-2) and inducible nitric 
oxide synthase (iNOS) [7]. Studies have shown 
that NO up-regulates the production of MMPs 
and inflammatory cytokines in OA [8]. Moreover, 
studies have suggested activated 
phosphatidylinositol 3-kinase (PI3K) - protein 
kinase B (Akt) pathway to be associated in 
regulating chondrocyte survival [9]. Thus 
compounds that could inhibit the effects of IL-1β 
and modulate the NF-κB, PI3K/Akt and MAPK 
signalling pathways and prevent cartilage 
degradation are of great clinical value in the 
therapy of OA.  
 
Recently, several researchers have focused on 
the effects of plant-derived compounds in curbing 
inflammatory responses in arthritis. Astragalin, a 
bioactive component from Rosa agrestis [10] and 
piperine derived from Piper nigrum exhibited anti-
inflammatory effects in OA model [11]. In our 
study, we investigated the effects of nobiletin in 
IL-1β-induced OA. Nobiletin, a polymethoxylated 
flavone found in citrus peels has been reported 
to possess various biological properties as anti-
cancer [12], anti-proliferative [13], anti-
inflammatory effects [14]. The present study was 
taken as an effort to explore the molecular 
events associated with the anti-inflammatory 




Chemicals and reagents 
 
Nobiletin was purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Antibodies against p38, JNK, 
ERK, p-p38, p-ERK, p-JNK, p-NF-κB p65, p-IκBα 
(Cell Signalling Technology Inc. Beverly, MA) 
Bad, Bax, Bcl-2, Bcl-xL, Akt, p-Akt, GSK-3β, p-
GSK-3β, mTOR, PTEN, iNOS, TNF-α and COX-
2 (Santa Cruz, CA,USA) were used for western 
blotting. Griess Reagent was purchased from 
Beyotime Institute of Biotechnology (Shanghai, 
China). DMEM, FBS, collagenase II, penicillin 
and streptomycin were purchased from Gibco 
BRL (Grand Island, NY, USA). Recombinant 
human IL-1β was purchased from (R&D 
systems. Minneapolis, MN, USA). All other 
chemicals used in the study were of analytical 
grade and were procured from Sigma-Aldrich (St. 
Loius, MO, USA) otherwise are specified. 
 
Chondrocyte isolation and cell culture 
 
Articular cartilage samples from 25 informed and 
consented patients (age: 57 ± 13) who were 
undergoing total knee replacement surgery were 
obtained. The study was approved by the 
institutional ethical committee. The articular 
cartilage was harvested from non-lesional areas 
and primary chondrocytes were isolated as 
described by Cheng et al [15].  
 
In brief, the tissues were digested with trypsin 
(0.25 %) for 30 min and further digested using 
collagenase II (0.2 %) in DMEM for 6 h at 37 °C. 
The cells were suspended in DMEM with 10 % 
fetal bovine serum (FBS), 100 U/mL of penicillin 
and 100 mg/mL of streptomycin and cultured at 
37 °C with 5 % CO2. On reaching 80 % 
confluence, the cells were pre-treated with 
nobiletin at 70, 150 or 300 μg/mL for 6 h and 
were subsequently treated with IL-1β (5 ng/mL) 
for 24 h. 
 
Cell viability assay 
 
The effect of nobiletin on the viability of 
chondrocytes was assessed by the MTT assay. 
The cells were seeded at a density of 6 x 103 in a 
96-well plate and were cultured overnight, 
following which the cells were treated with 
various concentrations of nobiletin for 24 h. The 
medium was discarded and 20 μL MTT (5 
mg/mL) was added to each well and incubated 
for 4 h. After discarding the supernatant, 150 μL 
of DMSO was added to solubilize the formazan 
crystals. The absorbance was measured at 570 
nm using a micro-plate reader (Bio-Rad, 
Hercules, CA, USA). 
 
Annexin V/PI staining 
 
Cell apoptosis was measured by annexin V-FITC 
and PI staining. Chondrocyte cells that were 
exposed to nobiletin for 6 h and IL-1β for 24 h 
were seeded in a 24-well plate at a density of 2 × 
105 cells per well. Apoptosis was detected using 
apoptosis detection kit (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). The cells 
were washed in PBS (phosphate buffered saline) 
and were then resuspended in binding buffer 
containing 100 μL FITC-conjugated anti-annexin 
V antibodies. The cells were analyzed for 
fluorescence using a flow cytometer (FACS 
Calibur, BD Biosciences).  
 
Determination of IL-6 and PGE2  
 
Chondrocytes were pre-treated with nobiletin for 
3 h and then stimulated with IL-1β for 24 h. The 
concentrations of IL-6 and PGE2 in the culture 
medium were measured by ELISA (R & D 
Systems, Minneapoils, MN). 
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NO concentration in the culture medium of the 
chondrocytes treated with various concentrations 
of nobiletin and IL-1β as described above for IL-6 
determination was assessed using Griess 
reagent as previously described by Au et al [16].  
 
RNA isolation and RT-PCR 
 
Real-time PCR was used to detect the 
expression of iNOS and COX-2. Total RNA was 
extracted using TriZol (Invitrogen) according to 
the manufacturer's instructions and quantified. 
RNA was quantified spectrophotometrically at 
260 nm (HP 8452A Diode Array 
Spectrophotometer). First strand cDNA was 
synthesized using 0.3 mg of the isolated RNA 
using DyNamoTM cDNA Synthesis Kit 
(Fermentas). Synthesized cDNA were amplified 
by PCR using the following primers: iNOS 
Forward - CCTTACGAGGCGAAGAAGGACAG, 
Reverse - CAGTTTGAGAGAGGAGGCTCCG; 
COX-2 Forward - GAGAGATGTATCCTCCCACA 
GTCA, Reverse – GACCAGGCACCAGACCA 
AAG. The relative expression of COX-2 and 
iNOS were normalized with GADPH (primers - 
Forward - TCTCCTCTGACTTCAACAGCGAC, 
Reverse - CCCTGTTGCTGTAGCCAAATT C). 
PCR was carried out as described by Ying et al 
[11].  
 
Western blot analysis 
 
Proteins extracted from chondrocytes treated 
with nobiletin (70, 150 or 300 µg/mL) and 
stimulated with IL-1β were subjected to western 
blotting. The cells were subjected to lysis buffer 
and the nuclear and cytoplasmic proteins were 
extracted from the cells using NE-PER 
Mammalian Protein Extraction Reagent 
(Thermo). Concentration of the isolated protein 
was determined using BCA protein assay kit 
(Bio-Rad Laboratories, USA). Equal amounts of 
protein samples (40 μg) were separated on SDS-
polyacrylamide gel (12 %) and transferred to 
PVDF membranes. The membranes were 
blocked with 5 % non-fat dry milk and were 
incubated with primary antibodies overnight at 4 
°C followed by incubation with peroxidase-
conjugated secondary antibodies at room 
temperature for 60 min. The immunoreactive 
bands were detected by enhanced 




Data are presented as mean ± SD (n = 3 or 6). 
Statistical significance between the means of 
various experimental groups were assessed by 
one-way analysis of variance (ANOVA) followed 
by Duncan’s Multiple Range Test as post-hoc 





Cytotoxic effects of nobiletin  
 
Articular chondrocytes incubated with nobiletin 
(75, 150 or 300 µg/mL) were subjected to MTT 
assay to assess if nobiletin had any cytotoxic 
effects. We observed that at all tested 
concentrations there was negligible effects on 
viability of chondrocytes (Fig. 1). The results 





Figure 1:  Influence of nobiletin on the cell viability of 
chondrocytes. Nobiletin had no cytotoxic effects on 
chondrocytes as determined by MTT assay; values 
are represented as mean ± SD, n = 6  
 
Nobiletin improves viability of chondrocytes 
exposed to IL-1β 
 
Annexin V/PI staining and flow cytometry assay 
was employed to assess apoptosis of 
chondrocyte on exposure to IL-1β. We observed 
apoptosis of chondrocytes stimulated with IL-1β. 
However, pre-treatment with nobiletin 
interestingly caused a decrease (p < 0.05) in 
apoptosis, with 300 µg concentration of nobiletin 
exhibiting maximum protective effects (Fig. 2). 
The low dose of 75 µg though decreased 
apoptosis, the trend of reduction was significantly 
lesser as compared to higher concentrations of 
150 and 300 µg. The results indicated that 
nobiletin effectively inhibited IL-1β- toxicity of 
chondrocytes. 
 
Further to assess the influence of nobiletin on the 
expression of apoptotic pathway proteins, we 
analysed the expression of pro-apoptotic (Bax 
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and Bad) and anti-apoptotic (Bcl-2 and Bcl-xL) 
proteins. IL-1β-stimulated chondrocytes 
expressed enhanced levels of pro-apoptotic 
proteins with decreased expression of Bcl-2 and 
Bcl-xL (Fig 2), suggesting raised apoptotic 
counts observed could have been due to raised 
levels of apoptotic protein expression. 
Interestingly, nobiletin caused significant up-
regulation in the levels of Bcl-2 and Bcl-xL while 
it down-regulated the expression of Bax and Bad. 
Thus, the results suggest the anti-apoptotic 
effects of nobiletin. 
Nobiletin inhibits IL-1β-induced NO and PGE2 
production 
 
NO and PGE2 levels in the culture medium of 
chondrocytes stimulated by IL-1β were 
determined. Markedly (p < 0.05) enhanced levels 
of NO and PGE2 were observed. Multi-fold 
increases in the level of NO were seen. 
Moreover, increased levels of inflammatory 
cytokine, 
                    
Figure 2: Nobiletin inhibited IL-1β- induced apoptosis of chondrocytes. Nobiletin inhibited apoptosis of 
chondrocytes induced by IL-1β determined by Annexin V staining (a); and also modulated the expression of 
apoptosis pathway proteins (b; values are represented as mean ± SD (n = 3). Key: L1 = control; L2 = IL-1β; L3 = 




Figure 3 Nobiletin inhibited IL-1β- induced apoptosis of chondrocytes. Nobiletin modulated the expression of 
apoptosis pathway proteins); values are represented as mean ± SD (n = 3); a represents statistical significance at 
p < 0.05 compared against control and b-f represents values within the same group that differ from each other at 
p < 0.05 as determined by one-way ANOVA followed by DMRT analysis. Key: L1 = control; L2 = IL-1β; L3 = IL-
1β + 75 µg nobiletin; L4 = IL-1β + 150 µg nobiletin; L5=IL-1β + 300 µg nobiletin) 
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IL-6 were also observed upon IL-1β exposure 
(Fig. 3). Nobiletin caused significant (p < 0.05) 
decrease in the levels of NO, PGE2 and 1L-6. 
The results suggest the potent anti-inflammatory 
effects of nobiletin. The 150 and 300 µg 
concentrations were more effective than 75 µg 
nobiletin. 
 
Nobiletin suppressed iNOS and COX-2 
expression 
 
IL-1β is known to induce the expression of COX-
2 and iNOS [7], eventually leading to the 
production of PGE2 and NO. Here we 
investigated whether nobiletin influenced 
expression of iNOS and COX-2. In line with 
previous studies, we also observed markedly 
elevated mRNA iNOS and COX-2 expression 
(Fig. 4) and as well raised expression of iNOS 
and COX-2 at the protein levels (Fig. 6) in 
chondrocytes stimulated with IL-1β. Nobiletin 
pre-treatment for 6 h caused a multi-fold 
decrease in the expression levels of both COX-2 
and iNOS. The reductions in the expression at 
both the mRNA and protein levels were found to 
be dose-dependent, with 300 µg concentration 
exerting maximum level of reduction. The 
reduction in the expression of IL-6, NO and 
PGE2 were in line with down-regulated COX-2 
and iNOS. The observations reveal that nobiletin-
induced decreased mRNA levels which could 
have contributed to reduced expressions of IL-6, 
NO and PGE2. 
 
Effect of nobiletin on expression of MAPK 
cascade proteins 
 
We assessed the expression of phosphorylated 
JNK, ERK and p38 MAPK. IL-1β stimulation 
caused a striking increase in the expressions of 
activated JNK, ERK and p38 MAPK (Fig. 5). 
Previous studies have shown enhanced 
expression of MAPKs under IL-1β stimulation 
[17]. However, nobiletin exposure resulted in 
significant down-regulation in the activation level 
of JNK, ERK and p38 MAPK. The 
phosphorylated JNK and p38 MAPK were highly 
reduced as compared to the p-ERK. The effects 
were similar at all the concentrations of nobiletin. 
The expression of ERK though reduced on 
exposure to nobiletin, the reduction was not 
significant as compared to JNK or p38MAPK. 
 
Nobiletin down-regulates NF-κB signalling 
 
NF-κB is a transcription factor that critically 
regulates expression of inflammatory mediators. 
To investigate whether nobiletin exhibited anti-
inflammatory effects via modulating the NF-κB 
pathway, the expression of NF-κB pathway 
proteins were detected. IL-1β caused 
significantly up-regulated expression of p-NF-κB 
p65, p-IκBα, IκBα and TNF-α. Pre-treatment with 
nobiletin for 6 h markedly (p < 0.05) down-
regulated the expression in a dose-dependent 
manner (Fig. 6). This down-regulation of the 
pathway could have possibly contributed to the 
decreased expression of inflammatory mediators. 
 
              
 
Figure 3: Influence of nobiletin on the levels of inflammatory mediators. Nobiletin effectively reduced levels of (a) 
PGE2 and IL-6 and (b) NO; values are represented as mean ± SD (n = 6); a represents statistical significance at 
p < 0.05 compared against control and b-f represents values within the same group that differ from each other at 
p < 0.05 as determined by one-way ANOVA followed by DMRT analysis 
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Figure 4: Effect of nobiletin on expressions of iNOS and COX-2. Nobiletin markedly reduced the expression of 
iNOS and COX-2 mRNA levels in IL-1β-induced chondrocytes (a and b); values are represented as mean ± SD 
(n = 6); a represents statistical significance at p < 0.05 compared against control and b-f represents values within 
the same group that differ from each other at p < 0.05 as determined by one-way ANOVA followed by DMRT 
analysis. Key: L1 = control; L2 = IL-1β; L3 = IL-1β + 75 µg nobiletin; L4 = IL-1β + 150 µg nobiletin; L5 = IL-1β + 
300 µg nobiletin) 
 
Influence of nobiletin on the PI3K/Akt 
signalling pathway 
 
To investigate the anti-inflammatory mechanisms 
of nobiletin, we also assessed the expression of 
Akt pathway proteins. IL-1β-induced 
chondrocytes exhibited elevated levels of Akt, 
phosphorylated Akt, phosphorylated GSK-3β and 
mTOR with decreased expression levels of 
PTEN. Nobiletin at all the three analysed 
concentration was observed to significantly (p < 
0.05) inhibit the phosphorylation of Akt and GSK-
3β (Fig. 7). Furthermore, PTEN expression was 
found to be up-regulated by nobiletin in a dose-
dependent manner. Nobiletin thus effectively 
regulates the PI3K/Akt signalling pathway and 
this in part also contributed to the decreased 
expressions of NF-κB. 
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Figure 5: Nobiletin modulates MAPK pathway proteins. Nobiletin significantly down-regulated the MAPK 
pathways and inhibited activation and phosphorylation of JNK and p38 MAPK with slight noticeable changes on 
the expressions of ERK (a and b); values are represented as mean ± SD (n = 6); a represents statistical 
significance at p < 0.05 compared against control and b-f represents values within the same group that differ from 
each other at p < 0.05 as determined by one-way ANOVA followed by DMRT analysis. Key: L1 = control; L2 = IL-
1β; L3 = IL-1β + 75 µg nobiletin; L4 = IL-1β + 150 µg nobiletin; L5 = IL-1β + 300 µg nobiletin) 
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Figure 6:  Nobiletin inhibiited NF-κB signalling pathway. IL-1β-induced activation of the NF-κB signaling 
cascades and expressions of COX-2 and iNOS were effectively modulated and regulated by nobiletin (a and b); 
values are represented as mean ± SD (n = 6); a represents statistical significance at p < 0.05 compared against 
control and b-f represents values within the same group that differ from each other at p < 0.05 as determined by 
one-way ANOVA followed by DMRT analysis. Key: L1 = control; L2 = IL-1β; L3=-IL-1β + 75 µg nobiletin; L4 = IL-




Osteoarthritis (OA) is a degenerative disease of 
the synovial joints that reduces quality of life [18]. 
Anti-inflammatory drugs prescribed for treating 
osteoarthritis are generally recommended for 
long term use. As individuals respond differently 
to drugs, chances of potential side effects remain 
as the major problem due to long term use of 
anti-inflammatory drugs. Recently, use of 
phytochemicals as anti-inflammatory agents is 
considered as an effective strategy to block 
inflammation in many inflammatory diseases 
such as OA [19]. In our study, we investigated 
the anti-inflammatory effects of nobiletin on IL-
1β-induced inflammation in human osteoarthritic 
chondrocytes. 
 
Role of inflammatory mediators NO and PGE2 is 
well known in the pathogenesis of OA and 
increased production of NO and PGE2 have 
been reported in patients with OA [20]. IL-1β, an 
important inflammatory cytokine, is a major 
catabolic factor associated with OA exerting 
critical roles in cartilage degradation [21]. 
Elevated levels of IL-1β have been observed in 
synovial fluid in OA [22]. IL-1β induces the 
expression of MMPs, such as MMP1, MMP3 and  
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Figure 7:  Nobiletin inhibited activation of PI3K/Akt signalling pathway. Nobiletin dose-dependently down-
regulated the expressions of proteins of the PI3K/Akt pathway, thereby inhibiting the pathway (a and b); values 
are represented as mean ± SD (n = 3); a represents statistical significance at p<0.05 compared against control 
and b-f represents values within the same group that differ from each other at p<0.05 as determined by one-way 
ANOVA followed by DMRT analysis. Key: L1 = control; L2 = IL-1β; L3 = IL-1β + 75 µg nobiletin; L4 = IL-1β + 150 
µg nobiletin; L5 = IL-1β + 300 µg nobiletin 
 
MMP13 that contribute to matrix degradation 
[23]. In addition, IL-1β induces the expression of 
iNOS and COX-2 and as well enhance the 
production of NO, PGE2 and IL-6 [11]. 
 
In the present study, we observed significant 
decrease in the levels of IL-6, NO and PGE2 as 
well as the expression of iNOS and COX-2 both 
at the mRNA and protein levels in response to 
pre-treatment with nobiletin. These observations 
suggest that nobiletin was able to effectively 
reduce the expression of inflammatory 
mediators, a hallmark event in OA therapy. 
Nobiletin improved chondrocyte cell viability in a 
dose-dependent manner and had no cytotoxic 
effects on chondrocytes that were not exposed to 
IL-1β. Nobiletin drastically altered the expression 
of apoptotic pathway proteins. Up-regulation of 
anti-apoptotic proteins with significant inhibition 
of pro-apoptotic proteins and caspase-3 in a 
dose-dependent way were also observed.  
 
It is known that NF-κB and MAPK signalling 
pathways play critical roles in the regulation of 
inflammatory mediators. To further analyse the 
effects of nobiletin, we assessed the expression 
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of NF κB and MAPK signalling pathway proteins. 
NF-κB is one of the most important cytokine-
induced transcription factors that critically 
regulate the expression of MMPs, COX-2, iNOS 
and other inflammatory cytokines [23]. Normally, 
NF-κB is bound to IκB inhibitor proteins in the 
cytoplasm. IL-1β stimulation induces p65 
phosphorylation and subsequent degradation of 
IκB that eventually leads to translocation of NF-
κB p65 into the nucleus that causes up-
regulation of inflammatory mediators [24]. In our 
study, nobiletin treatment caused remarkable 
down-regulation of phosphorylated NF-κB p65 
and IκBα. The observed decreased expression of 
COX-2, iNOS and TNF-α suggest the inhibition 
of NF-κB signalling pathway by nobiletin that 
possibly could have also contributed to 
decreased levels of PGE2 and NO.  
 
Previous studies have shown increased 
expression of MMPs, COX-2, and iNOS following 
stimulation of chondrocytes by IL-1β [25]. Thus, 
the results indicate that nobiletin exerts anti-
inflammatory effects via attenuation of NF-κB 
activity. Further, it has been reported that NF-kB 
signalling pathway mediates many of the 
biological effects of IL-1β on chondrocytes [26]. 
Thus inhibition of the pathway could be of 
immense clinical value in treatment of OA.  
 
PI3K and Akt are the upstream molecules in NF-
κB pathway and have critical role in NF-κB 
activation [18]. To assess the effects of nobiletin 
on PI3K/Akt signalling, the expression of the 
pathway proteins was analysed. IL-1β caused 
multi-fold increased expression of 
phosphorylated Akt and GSK-3β, indicating 
activation of the pathway. Nobiletin pre-treatment 
significantly inhibited the pathway as observed 
by decreased phosphorylation of Akt. The results 
suggest the possible involvement of PI3K/Akt 
cascades in nobiletin-induced inhibition of NF-κB 
activation. 
 
MAPK pathways also exert critical effect the 
regulation of inflammatory cytokines production 
[27]. Binion et al. [28] reported that the activation 
of Akt further caused activation of MAPK 
pathways. Stimulating chondrocytes by IL-1β has 
been shown to induce phosphorylation and 
activation of ERK1/2, JNK, and p38 MAPKs [17]. 
In our study, enhanced expression of MAPK 
pathway proteins JNK, ERK and p38 were 
observed following IL-1β which is similar to the 
results of previous studies [10, 17]. Nobiletin 
down-regulated the MAPK activation as 
evidenced by significant decrease in the 
expression of JNK, ERK and p38. Comparatively 
with the extent of JNK and p38 MAPK 
expression, ERK expression did not exhibit 
drastic changes, though some noticeable 
changes were seen. Nobiletin was able to 
effectively down-regulate MAPK pathways in IL-
1β stimulated chondrocytes which also in part 
could be responsible for reduced levels of 




Collectively, the observed results reveal the ant-
inflammatory effects of nobiletin. Since nobiletin 
effectively modulates the critical pathways 
involved in OA pathogenesis, it requires further 
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